New plant varieties can represent years of breeding, testing and commercial investment. Plant breeder’s rights can help protect that value, but they are often only one part of the picture. For breeders, growers, nurseries and agtech businesses, early planning around PBRs, trade marks, confidential information, licensing and overseas protection can make a significant difference.

Hunter businesses looking to grow into ASEAN markets should think about intellectual property early. Trade marks, patents, confidential know-how and commercial agreements can all become more complicated overseas, so understanding what you own and what needs protecting before entering a new market can save significant time and cost later.

For many businesses, the assets creating the most value are not physical. Brands, software, technology, data, designs and know-how can all be critical intangible assets. We look at why identifying, owning and protecting that IP matters for growth, investment and business value.

Before approaching retailers, distributors or manufacturers, food businesses should make sure their IP foundations are in place. From trade mark protection and confidential recipes to packaging, ownership and supplier agreements, a few early checks can help avoid costly problems as a product moves into larger markets.

Glasgow 2026 shows why businesses need a practical international trade mark strategy that protects key growth markets without wasting budget.

Who owns the ideas your employees or contractors create? Learn how IP ownership works for inventions, designs and creative work in regional businesses, and why clear contracts matter.

NSW’s Regional Business Improvement Program helps manufacturers boost efficiency—but modernisation can expose valuable IP. Learn how to protect ownership of software, processes, and know-how as you upgrade operations and avoid costly mistakes.

AI is transforming how new drugs are discovered and developed—but it’s also raising new challenges for patent protection. Learn how AI is reshaping pharmaceutical innovation, ownership, and IP strategy in a rapidly evolving landscape.